About Lucid Diagnostics, Inc. 
Lucid Diagnostics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 16 Schemes (10.52%)
Foreign Institutions
Held by 16 Foreign Institutions (0.62%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Dec 2025)
Net Profit:
-16 Million
Pharmaceuticals & Biotechnology
USD 184 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.93
-184.58%
7.10






